CMS released several improper payment estimates for fiscal year (FY) 2026, highlighting payment accuracy issues across Medicare, Medicare Advantage (MA), and other programs.Read More »
A new Office of Inspector General (OIG) data brief highlights potential weaknesses in CMS’ and Medicare Administrative Contractors’ (MAC) oversight of Part B outpatient drug billing.Read More »
Q: What should revenue integrity teams at short-term acute care hospitals keep in mind before analyzing Program for Evaluating Payment Patterns Electronic Report (PEPPER) findings?Read More »
Understanding PEPPER is the first step in using it effectively. Julie Hall, EHRC, CRCR, COC, co-founder and principal consultant at Integrated Revenue Integrity in Sturbridge, Massachusetts. recommends referencing the PEPPER user guide, which is updated with the publication of...Read More »
A bipartisan group of senators introduced a bill in early August to clarify requirements, increase oversight, and reform the payment and data infrastructure of the 340B Drug Pricing Program. Read More »